There is one clinical trial.
The investigators hypothesize that the intake of Omni-Biotic® 10 AAD can reduce the duration of diarrhea in Covid-19 disease. The investigators further hypothesize that Omni-Biotic® 10 AAD can reduce stool frequency, improve stool consistency, improve other gastrointestinal symptoms of Covid-19, reduce disease duration and severity, reduce intestinal inflammation and can improve dysbiosis. The investigators aim to perform a randomized, double blind, placebo-controlled study using telemedicine in patients with Covid-19 disease.
Description: Duration of diarrhea (defined as days with 3 or more loose stools)Measure: Diarrhea Time: 30 days
Description: stool evacuations per daysMeasure: Stool frequency Time: 30 days
Description: Stool consistency according to Bristol stool scale for each evacuation, score 1-7, a higher score means a lower stool consistancyMeasure: Stool consistency Time: 30 days
Description: presence of anorexia, nausea, vomiting, abdominal pain, bloating (yes/no)Measure: Gastrointestinal symptoms Time: 30 days
Description: days patients feel sick, are not able to work or are on sick leaveMeasure: Duration of Covid-19 disease Time: 30 days
Description: mild/moderate/severeMeasure: Severity of Covid-19 disease Time: 30 days
Description: measured by ELISAMeasure: Stool Calprotectin Time: 30 days
Description: measured by ELISAMeasure: Stool Zonulin Time: 30 days
Description: 16S RNA sequencingMeasure: Microbiome composition Time: 30 days
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports